0001134505-05-000002.txt : 20120607
0001134505-05-000002.hdr.sgml : 20120607
20050330110204
ACCESSION NUMBER: 0001134505-05-000002
CONFORMED SUBMISSION TYPE: SC 13G
CONFIRMING COPY:
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20050330
DATE AS OF CHANGE: 20050330
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: LARGE SCALE BIOLOGY CORP
CENTRAL INDEX KEY: 0001108951
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770154648
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SC 13G
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-60663
BUSINESS ADDRESS:
STREET 1: 3333 VACA VALLEY PKWY
STREET 2: STE 1000
CITY: VACAVILLE
STATE: CA
ZIP: 95688
MAIL ADDRESS:
STREET 1: 3333 VACA VALLEY PARKWAY SUITE 1000
CITY: VACAVILLE
STATE: CA
ZIP: 95688
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: TECHNOLOGY DIRECTORS II LLC
CENTRAL INDEX KEY: 0001134505
IRS NUMBER: 000000000
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SC 13G
BUSINESS ADDRESS:
STREET 1: 460 BLOOMFIELD AVE.
STREET 2: SUITE 200
CITY: MONTCLAIR
STATE: NJ
ZIP: 07042
BUSINESS PHONE: 18889079200
MAIL ADDRESS:
STREET 1: 460 BLOOMFIELD AVENUE
STREET 2: SUITE 200
CITY: MONTCLAIR
STATE: NJ
ZIP: 07042
SC 13G
1
td2lgs13g021205.txt
United States
Securities and Exchange Commission
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
Large Scale Biology Corporation
-----------------------------------------------
(Name of Issuer)
Common Stock, par value $0.001 per share
--------------------------------------------------------------
(Title of Class of Securities)
517053 10 4
---------------------------
(CUSIP Number)
December 31, 2004
---------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which
this Schedule is filed:
[ ] Rule 13d-1 (b)
[ ] Rule 13d-1 (c)
[X ] Rule 13d-1 (d)
*The reminder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the
subject class of securities, and for any subsequent amendment
containing information which would alter the disclosures provided
in a prior cover page.
The information required in the remainder of this cover page shall
not be deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that
section of the Act but shall be subject to all other provisions of the Act
(however, see the Notes).
CUSIP No. 517053 10 4
------------------------------------------------------------
1. Name of Persons Reporting
Technology Directors II, LLC
I.R.S. Identification Nos. of above persons (entities only).
13-394-7852
-----------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group
(a)
(b) x
----------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
---------------------------------------------------------------------------
5. Sole Voting Power
Number of 3, 667,453
Shares -----------------------------------------------------
Owned by 6. Shared Voting Power
Each 0
Reporting Person -----------------------------------------------------
With
7. Sole Dispositive Power
3, 667,453
-----------------------------------------------------
8. Shared Dispositive Power
0
-------------------------------------------------
9. Aggregate Amount Beneficially Owned by each Reporting Person
3, 667,453
-----------------------------------------------------------
10. Check if Aggregate Amount in Row (9) Excludes Certain Shares
------------------------------------------------------
11. Percent of Class Represented by Amount in Row 9
14.1
---------------------------------------------------------------------
12. Type of Reporting Person
00
----------------------------------------------------------------------
CUSIP No. 517053 10 4
--------------------------------------------------------------------------
1. Names of Reporting Persons.
Technology Directors II, LLC
I.R.S. Identification Nos. of above persons
13-3547852
-------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group
(a)
(b)
----------------------------------------------------------------------
3. SEC Use Only
---------------------------------------------------------------------
4. Citizenship or Place of Organization
Delaware
-----------------------------------------------------------------
Number of 5. Sole Voting Power
Shares
Beneficially 3, 667,453
Owned by ----------------------------------------------------------------
Each
Reporting Person 6. Shared Voting Power
With
0
--------------------------------------------------------------------------
7. Sole Dispositive Power
3, 667,453
--------------------------------------------------------------------------
8. Shared Dispositive Power
0
---------------------------------------------
9. Aggregate Amount Beneficially Owned by each Reporting Person
3, 667,453
-----------------------------------------------------------------------
10. Check if Aggregate Amount in Row (9) Excludes Certain Shares
0
------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row (11)
14.1%
-------------------------------------------------------------------------
12. Type of Reporting Person
00
---------------------------------------------------------------------
Item 1(a) Name of Issuer:
Large Scale Biology Corporation
Item 1(b) Address of Issuer's Principal Executive Offices:
333 Vaca Valley Parkway
Suite 1000
Vacaville, CA 95688
Item 2(a) Name of Person Filing: Technology Directors II, LLC
Item 2(b) Address of Principal Business Office:
The address of the principal business office is
460 Bloomfield Avenue, Suite 200, Montclair, NJ 07042.
Item 2(c) Citizenship:
Delaware.
Item 2(d) Title of Class of Securities:
Common Stock, par value $0.001 per share.
Item 2(e) CUSIP No.:
517053 10 4
Item 3 If this Statement is Filed Pursuant to Rule 13d-1(b) or 13d-2(b)
or (c), Check Whether the Person Filing is a :
Not Applicable
Item 4 Ownership:
Technology Directors II, LLC. Is the beneficial owner and has sole
power to vote or to direct the vote and sole power to vote
or dispose of 3,667,453 shares of Common Stock, constituting
approximately 14.1% of Common Stock.
Item 5 Ownership of Five Percent or Less of a Class:
If this statement is being filed to report the fact that as of the date
hereof each of the Reporting Persons has ceased to be the beneficial owner of
more than five percent of the class of securities, check the following [ ].
Item 6 Ownership of More than Five Percent on Behalf of Another
Person:
See reponse to Item 4. Any such interest does not relate to more than
five percent of the Common Stock outstanding as of December 31, 2000.
Item 7 Identification and Classification of the Subsidiary which Acquired
the Security being Reported on by the Parent Holding Company:
Not Applicable
Item 8 Identification and Classification of Members of the Group:
Not Applicable
Item 9 Notice of Dissolution of Group:
Not Applicable.
Item 10. Certifications:
Not Applicable.
SIGNATURE
After reasonable inquiry and to the best of our knowledge and belief, the
undersigned certify that the information set forth in this statement is true,
complete and correct.
Date: February 11, 2005
Technology Directors II, LLC
By: -------------------------------------------
John J. O'Malley
Managing Member